Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Hwk-016, Mucin-16-Targeted Adc
Hereditary Thrombophilia Due To Congenital Protein C Deficiency
Whitehawk Therapeutics, Inc.
P1
CC
(43)
Hyaluronate
Interstitial Cystitis
Sverdlovsk Regional Clinical Hospital No.1
P1
CC
(43)
Hydrocortisone
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia Consortium
P1
CC
(43)
Hydrocortisone
Juvenile Myelomonocytic Leukemia
Children's Oncology Group
P1
CC
(43)
Hydrocortisone
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Andrew E. Place, MD
P1
CC
(43)
Hydroxyurea
Refractory Malignant Neoplasm
Bionoxx Inc.
P1
CC
(43)
Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid
Human Papillomavirus-Related Squamous Cell Carcinoma
Pamela Munster
P1
CC
(43)
Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid
PIK3CA-Related Overgrowth Spectrum
Pamela Munster
P1
CC
(43)
Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid
Subarachnoid Hemorrhage
University of Maryland, Baltimore
P1
CC
(43)
iam1363
Metastatic Malignant Neoplasm In The Brain
Iambic Therapeutics, Inc
P1
CC
(43)
iam1363
HER2 Positive Breast Carcinoma
Iambic Therapeutics, Inc
P1
CC
(43)
iam1363
Gastric Cancer
Iambic Therapeutics, Inc
P1
CC
(43)
iam1363
Neoplasm
Iambic Therapeutics, Inc
P1
CC
(43)
iam1363
Urinary Bladder Cancer
Iambic Therapeutics, Inc
P1
CC
(43)
iam1363
Colorectal Cancer
Iambic Therapeutics, Inc
P1
CC
(43)
iam1363
Gastroesophageal Cancer
Iambic Therapeutics, Inc
P1
CC
(43)
Ibio-600
Obesity Disorder
iBio, Inc.
P1
CC
(43)
ibr900 cell
B-Cell Non-Hodgkin Lymphoma
Imbioray (Hangzhou) Biomedicine Co., Ltd.
P1
CC
(43)
Ibrutinib
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Ibrutinib
Ependymoma
Theodore S. Johnson
P1
CC
(43)
Ibrutinib
Medulloblastoma
Theodore S. Johnson
P1
CC
(43)
Ibrutinib
Primary Brain Neoplasm
Theodore S. Johnson
P1
CC
(43)
Ibrutinib
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Ibrutinib
Melanoma
Mayo Clinic
P1
CC
(43)
ic9-car19 t cells
Immune System Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Showing 2351 to 2375 of 9,928 assets
Previous
Page 95 of 398
Next
